Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?

Published:2010-06 Issue: Volume: Page:93
ISSN:1178-7058
Container-title:International Journal of Nephrology and Renovascular Disease
language:en
Short-container-title:IJNRD

Author:

Ripley Elizabeth

Publisher

Informa UK Limited

Subject

Nephrology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational screening of potential AT1R inhibitors fromNigella sativafor diabetic-hypertensive therapy;2024-08-30

2. The natural history of hypertension in older adults: a study of two Finnish generational cohorts born 20 years apart;Blood Pressure;2024-06-24

3. Marked Hepatotoxicity Associated With Losartan Treatment: A Case Report;Cureus;2023-12-02

4. Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial;The Journal of Clinical Hypertension;2023-09-11

5. Moderate dose of dietary nitrate improves skeletal muscle microvascular function in patients with peripheral artery disease;Microvascular Research;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP